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elucidation of most biosynthetic steps leading to glyco-
peptide formation, after establishing the biochemical
properties of selected gene products overproduced in
E. coli [7–15] or through the genetic manipulation of
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Italy 15–19]. Interestingly, novel glycopeptide derivatives
have also been generated through the manipulation of
the balhimycin pathway [20] or through in vitro glycosy-
latyion of glycopeptide aglycones [13, 21, 22]. However,Summary
this work has been carried out mostly on the vancomycin
type of glycopeptide antibiotics. Apart from the descrip-The glycopeptide A40926 is the precursor of dalbavan-
tion of the gene cluster of A47934 [6], a glycopeptidecin, a second-generation glycopeptide currently under
devoid of any sugar, no detailed information is availableclinical development. The dbv gene cluster, de-
on glycopeptides of the teicoplanin family.voted to A40926 biosynthesis, was isolated and charac-
The antibiotic A40926 [23] belongs to the teicoplaninterized from the actinomycete Nonomuraea species
family of glycopeptides (Figure 1). It consists of a com-ATCC39727. From sequence analysis, 37 open reading
plex of closely related molecules sharing a heptapeptideframes (ORFs) participate in A40926 biosynthesis, reg-
skeleton with a rigid scaffold determined by ether bondsulation, resistance, and export. Of these, 27 ORFs find
between amino acids 1–3, 2–4, and 4–6, and a C-C bonda match in at least one of the previously characterized
between amino acids 5–7. In addition, two sugar resi-glycopeptide gene clusters, while 10 ORFs are, so far,
dues and two chlorine atoms are present on the mole-unique to the dbv cluster. Putative genes could be
cule. The components of the A40926 complex differ inidentified responsible for some of the tailoring steps
the length of the acyl chain, with factor A1 (R  n-decyl)(attachment of glucosamine, sugar oxidation, and
as the main component (Figure 1). Besides showing anmannosylation) expected during A40926 biosynthesis.
intrinsic antibacterial activity, A40926 is the precursorAfter constructing a Nonomuraea mutant by deleting
of the semisynthetic glycopeptide dalbavancin (formerlydbv ORFs 8 to 10, the novel compound dechloroman-
known as BI397 or MDL 62,397), currently under clinicalnosyl-A40926 aglycone was isolated.
development [2].
The A40926 producer strain was formerly known as
Introduction Actinomadura species ATCC39727 [23]. Following a re-
classification of the genera Actinomadura and Microte-
Glycopeptides are an important class of antibiotics that traspora and a further reanalysis of the latter genus, the
interfere with bacterial cell wall synthesis, with vanco- A40926 producer has been classified as a Nonomuraea
mycin and teicoplanin currently used in the clinic for species [24]. We describe here the characterization of
treating life-threatening infections caused by gram-pos- the dbv (from dalbavancin) cluster involved in A40926
itive bacteria [1]. The emergence of resistance to glyco- formation in Nonomuraea species ATCC39727 and
peptides among enterococci and the fear that this high- show that it is possible to genetically manipulate this
level resistance may eventually become widespread in pathway.
methicillin-resistant Staphylococcus aureus has prompted
the search for second-generation drugs of this class.
Promising results have been obtained with the develop- Results and Discussion
ment of semisynthetic derivatives with improved activ-
ity, expanded antibacterial spectrum, or better pharma- Identification of the dbv Cluster
cokinetics [2]. Chemically, glycopeptide antibiotics A cosmid library of Nonomuraea species ATCC39727
consist of a heptapeptide core characterized by exten- DNA was screened with homologous, heterologous, and
sive crosslinking of the aromatic side chains. Vancomy- synthetic probes (see Experimental Procedures) fol-
cin and teicoplanin are actually representatives of two lowed by chromosome walking. This approach led to
distinct families of glycopeptides that exhibit different the identification of seven overlapping cosmids encom-
antibacterial properties. Vancomycin is more active than passing the 120 kb genomic segment reported in Figure
teicoplanin against coagulase-negative staphylococci, 2. The central region of this segment was sequenced,
while teicoplanin possesses more favorable pharmaco- resulting in a contiguous stretch of 89,153 nt. As de-
kinetic properties than vancomycin. scribed below, the dbv cluster consists of 37 open read-
Following the characterization of the first gene cluster ing frames (ORFs), designated ORF1 through ORF37.
involved in the formation of the glycopeptides chloroere- These ORFs are illustrated in Figure 3, and their relevant
momycin [3], the genetic elements responsible for balhi- features are summarized in Table 1.
mycin [4], complestatin [5], and A47934 [6] formation The probable boundaries of the dbv cluster were es-
have been described. This information has allowed the tablished by comparison with other glycopeptide clus-
ters and from the deduced functions of the dbv gene
products. On its left end (Figure 3), the dbv cluster is*Correspondence: sdonadio@vicuron.it
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-hydroxytyrosine (HT). ORFs 1 and 2 (Table 1) show
considerable sequence identity to Hmo and p-hydroxy-
mandelate synthetase (HmaS), respectively, which are
required to convert p-hydroxyphenylpyruvate into
p-hydroxyphenylglyoxylate during HPG synthesis [8,
12]. ORFs 31 to 34 are closely related to DpgA through
DpgD, respectively (Table 1), which are required for DPG
formation [10, 16]. dbv ORF37 encodes a homolog of
HpgT, the amino transferase required for the transami-
nation of both p-hydroxyphenylglyoxylate and 3,5-dihy-
droxyphenylglyoxylate, to yield HPG and DPG, respec-
tively [8, 16]. Thus, the seven genes required for HPG and
DPG synthesis are also present in the dbv cluster. dbv
ORF5, which encodes a homolog of prephenate dehydro-
genase, may also participate in HPG synthesis. This func-
tion is likely to provide the initial p-hydroxyphenylpyruvate
for HPG synthesis. Since HpgT uses Tyr preferentially asFigure 1. Structure of A40926
an amino donor, conversion of p-hydroxyphenylglyoxylate
into HPG generates further p-hydroxyphenylpyruvate,
likely to be delimited by ORF1 encoding a homolog of which can be acted upon directly by Hmo [8].
p-hydroxymandelate oxidase (Hmo), one of the enzymes In balhimycin and chloroeremomycin formation, con-
involved in p-hydroxyphenylglycine (HPG) synthesis [8, version of Tyr into HT requires the participation of three
12]. The deduced products of the next two ORFs to the enzymes, one for covalent attachment of Tyr to a carrier
left of dbv ORF1 (Figure 3) show significant identity to protein, one for the actual hydroxylation, and the third
Streptomyces coelicolor proteins but not to sequences (presumably) for hydrolytic release of HT from the pro-
from other glycopeptide clusters. Thus, we assume that tein carrier [19, 26]. However, homologs of the corre-
ORF1 delimits the left end of the dbv cluster. The right sponding genes are absent from the dbv and sta clus-
side of the dbv cluster is probably delimited by the ters, which instead specify polypeptides containing
remnant of an attachment site (attL*, Table 1) showing motifs typical of nonheme iron dioxygenases, exempli-
80% identity to the attL site of the Streptomyces vene- fied by dbv ORF28 (Table 1). Homologs of these poly-
zuelae VWB phage, which inserts into a putative tRNAArg peptides are also encoded by the chloramphenicol [27]
gene [25]. Further to the right of this sequence, the next and ramoplanin [28] clusters. A single -hydroxylated
two ORFs, while similar to database sequences, find no Phe or Asn residue, respectively, is present in the pep-
counterparts in other glycopeptide clusters. The orienta- tide skeletons of these compounds. At the moment we
tion of dbv attL* suggests that its cognate attR site, if do not know if these apparently convergent pathways
present, should be situated to its left in Figure 2. How- for HT formation are interchangeable in glycopeptide
ever, we were unable to locate any sequence resembling formation.
an attR site in the remaining 77 kb of Nonomuraea DNA Synthesis of the Heptapeptide
sequence. Considering the interval comprised between Synthesis of the A40926 heptapeptide precursor is cata-
ORF1 and attL*, the dbv cluster spans approximately lyzed by a nonribosomal peptide synthetase (NRPS). In
71 kb. NRPSs, each elongating module is characterized by the
presence of at least three domains: an adenylation (A)
Deduced Functions of the dbv Gene Products domain responsible for substrate recognition and acti-
Putative roles could be assigned by sequence analysis vation, a thiolation (T) domain, which covalently binds
to most of the 37 dbv ORFs. All together, 27 of the 37 dbv amino acids and elongating peptides as thioesters; and
ORFs find homologs in at least one other glycopeptide a condensation (C) domain, which catalyzes peptide
cluster (Table 1). The following sections summarize bond formation. The initiation module does not usually
these findings, grouping ORFs governing similar por- contain a C domain. In addition to these core domains,
tions of a hypothetical A40926 pathway. an epimerization (E) domain is usually present in those
Synthesis of Nonproteinogenic Amino Acids modules that convert an L amino acid into the D form.
Formation of the A40926 heptapeptide skeleton is ex- The last module is usually completed by a thioesterase
pected to require the specialized synthesis of three (Te) domain, which hydrolyzes the thioester bond linking
the completed peptide to the NRPS [29].amino acids: HPG, dihydroxyphenylglycine (DPG), and
Figure 2. Cloned Portion of the Nonomuria
Species ATCC39727 Chromosome
The thick line denotes the sequenced seg-
ment and the cosmids 11A5, 7F3, 7E9, 1B1,
7A2, 11B9, and 7C7 are indicated by the thin
lines below.
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Figure 3. Genetic Organization of the dbv Cluster
The orientation is the same as in Figure 2. Each ORF is represented by an arrow, numbered as in Table 1, except for the NRPS genes, which
are indicated by thick arrows showing the encoded domains. The ORFs unique to the dbv cluster are indicated in gray. Numbers on the scale
bars indicate sequence coordinates (in kb).
The dbv ORFs 16, 17, 25, and 26 encode the 7-module of E domains suggest a NH2-L-D-L–D-D-L-L-COOH ste-
reochemistry. The A domain from cep module 1 usesNRPS required for A40926 formation. Specifically, the
domain compositions of dbv ORF25 (A-T-C-A-T-E) and L-Leu preferentially over D-Leu [9]. Thus, there is one
missing E domain in module 1 and an extra domain inORF26 (C-A-T) strongly indicate that the former encodes
modules 1 and 2, and the latter encodes module 3. The module 7.
It should be noted that in all other glycopeptide clus-domain composition deduced from dbv ORF17 (C-A-T-
E-C-A-T-E-C-A-T) suggests that it encodes modules 4 ters characterized thus far, there is colinearity between
gene order and role of modules. The dbv NRPS, how-through 6. dbv ORF16 is highly related to modules 7
from other glycopeptide NRPSs, since it specifies the ever, is encoded by two divergently transcribed gene
pairs separated by about 12 kb (see Figure 3). Withindomain sequence C-A-T-X*-Te (X* denotes an atypical
C or E domain of unknown function). This attribution of each pair, colinearity is maintained, since the gene en-
coding modules 1 and 2 precedes that encoding modulethe dbv ORFs to the NRPS modules is also consistent
with the expected amino acid specificities of the corre- 3, and ORF17, encoding modules 4 to 6, precedes
ORF16. The possibility that this atypical organization issponding A domains deduced from the nonribosomal
code [30, 31]. Indeed, the signature amino acids from due to some cloning artifact seems unlikely. First, the
segments encoding the NRPS are present in more thanthe A domains from modules 1, 4, and 5 show significant
matches to HPG-specific A domains, and those from one cosmid (Figure 2) and were thus recovered by inde-
pendent cloning events. In addition, the region com-module 7 show significant matches to DPG-recognizing
A domains. The matches of the signature sequences prised between the two blocks of NRPS genes encodes
other ORFs likely involved in A40926 biosynthesis (Tablefrom the other A domains, while not as significant, are
nonetheless consistent with module 2 and 6 recognizing 1). At least one precedent exists for noncolinearity in
actinomycete NRPS genes [32].a Tyr derivative and module 3 recognizing a DPG
residue. Two other dbv ORFs are likely to participate in hepta-
peptide synthesis. ORF15 (Table 1) encodes a short,The dbv, com, and sta NRPS each consist of four
different polypeptides, and not of three as for the bal highly conserved peptide of unknown function, speci-
fied by many actinomycete clusters containing NRPSand cep systems. In terms of domain composition, all
five NRPSs present the same organization, except for genes. The corresponding gene is always found down-
stream of the Te-encoding gene. ORF36 (Table 1) en-the existence of an additional E domain (presumed to
be inactive) in com and sta modules 3 and a putative codes a type II thioesterase, a function often specified
by clusters containing NRPS or polyketide synthasemethylation domain in com module 6 (proposed to
N-methylate amino acid 6). Interestingly, all five glyco- genes. The proposed role for these thioesterases is to
hydrolyze misprimed or misacylated T domains [33, 34].peptide NRPSs present an additional domain in module
7 (we have referred to this additional domain as X*). Its Crosslinking and Chlorination
of Aromatic Residuespresence at the same location suggests an important
role in heptapeptide synthesis. In this respect, it should The A40926 aryl groups are joined by three ether links
and one C-C link (Figure 1). As demonstrated for balhi-be noted that the structures of the five glycopeptides
imply a heptapeptide precursor of NH2-D-D-L-D-D-L-L- mycin, these crosslinking reactions are carried out by
P450 monooxygenases encoded by three separate oxyCOOH stereochemistry, while the number and position
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Table 1. dbv ORFs
Clustera Best Matchb
dbv ORF bal cep com sta Sourced Entrye Scoref Proposed Functionc
1     sta Hmo
2     sta HmaS
3     S. hygroscopicus T03225 9e-90 positive regulator
4     cep positive regulator
5     cep prephenate dehydrogenase
6     S. coelicolor Q03576 9e-84 response regulator
7     Synechocystis sp. S77033 8e-04 carboxypeptidase
8     ND unknown
9     cep glycosyltransferase
10     sta halogenase
11   -  sta P450 monooxygenase
12     cep P450 monooxygenase
13     sta P450 monooxygenase
14     bal P450 monooxygenase
15     cep unknown
16     cep NRPS, module 7
17     sta NRPS, nodules 4-6
18     S. coelicolor CAB89462.1 4e-58 ABC transporter
19     S. coelicolor CAB89461.1 3e-67 ABC transporter
20     S. coelicolor CAC32663.1 6e-59 mannosyltransferase
21     bal unknown
22     S. hygroscopicus T30222 2e-49 sensor protein kinase
23     M. loti NP_103545.1 1e-58 acyltransferase
24     sta ABC transporter
25     sta NRPS, modules 1-2
26     sta NRPS, module 3
27     cep methyltransferase
28     sta -hydroxylase
29     S. coelicolor NP_630371.1 e-126 hexose oxidase
30     S. coelicolor NP_626911.1 2e-18 4HB-CoA thioesterase
31     bal DpgA
32     bal DpgB
33     bal DpgC
34     cep DpgD
35     bal membrane ion antiporter
36     A. mediterranei AAG52991.1 2e-25 thioesterase
37     cep HpgT
attL*     S. coelicolor SCO939123 4e-23 attachment site
List of dbv ORFs and the best matching sequences.
a Existence of a homolog in other glycopeptide clusters: “” denotes its presence, and “” denotes its absence.
b Best match found by Blast searches in GenBank other than glycopeptide clusters.
c Proposed function in A40926 biosynthesis.
d Organism originating the best matching sequence. When bal, cep, com, or sta are reported, it indicates that the best matching sequence
derives from one of these clusters. A., Amycolatopsis; M., Mesorhizobium; S., Streptomyces; ND, none detected.
e Accession number of the best matching sequence.
f Probability score of the best matching sequence.
genes [17, 18]. The dbv cluster contains four such genes, (Figure 1), and on one residue each of Tyr, HPG, and
HT in A47934. Two chlorine atoms are present on onenamely ORFs 11 through 14 (Table 1), as does the sta
cluster, consistent with the four crosslinks present in p-hydroxyphenylglyoxylate and on two HPG residues in
complestatin. A single halogenase gene, specified bythe corresponding glycopeptides. A role for each P450
enzyme has been proposed on the basis of the partially ORF10 (Table 1), is present in the dbv cluster. As shown
below, this ORF is very likely responsible for the intro-crosslinked metabolites produced after selective inacti-
vation of the oxy genes in A. mediterranei [17, 18]. From duction of both chlorine atoms in A40926, as it occurs
in A. mediterranei [19]. Thus, there is apparently no cor-sequence similarities (Table 1), it is likely that dbv ORFs
11, 12, and 14, which are best related to OxyC, OxyB, relation between the number of halogenase genes (one
for each cluster, except two for sta) and the numberand OxyA, respectively, are involved in crosslinking of
amino acids 5–7, 4–6, and 2–4. By exclusion, ORF13 and position of chlorine atoms in the corresponding
glycopeptides. Understanding the timing and specificityshould be involved in crosslinking of amino acids 1–3.
Glycopeptides present different degrees of chlorina- of halogenation might expand the positions at which
glycopeptides are chlorinated. Interestingly, the pres-tion. In fact, one chlorine atom is present on each of
the two HT residues in balhimycin and chloroeremo- ence of chlorine atoms appears to enhance antibacterial
activity in some glycopeptides [35].mycin, on one residue each of HT and DPG in A40926
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Addition and Modification of Sugars, Resistance, Export, Regulation, and Unknown
Functionsand N-Methylation
The deduced product of ORF7 contains motifs typical ofThe following modifications are expected to occur on
the VanY-family of carboxypeptidases (Table 1). Thesethe newly formed A40926 aglycone: N-methylation of
enzymes are involved in the extracytoplasmic removalthe terminal HPG residue, addition of a glucosamine
of the terminal alanine residue from nascent peptidogly-moiety to the hydroxyl group of amino acid 4, N-acyla-
can, reducing the extent of glycopeptide binding to itstion of the glucosamine residue, oxidation of the primary
molecular target [39]. dbv ORF7 may thus be involvedalcohol of the glucosamine moiety to yield a carboxyl
in conferring some level of A40926 resistance to thegroup, and addition of a mannose residue to the hy-
producing strain. Like its homolog from the bal clusterdroxyl group of amino acid 7 (Figure 1). Five proteins,
(W. Wohlleben, personal communication), it resemblesencoded by dbv ORFs 9, 20, 23, 27, and 29, are likely
the VanY-family of carboxypeptidases, which in vanco-to be involved in these tailoring steps. Only ORFs 9
mycin-resistant enterococci represent ancillary resis-and 27 find counterparts in other glycopeptide clusters
tance determinants. It thus appears that different resis-(Table 1).
tance mechanisms are operating in glycopeptideThe deduced sequence of ORF9 is highly related to
clusters, with vanHAX-like genes present in the sta [6]the GtfB glycosyltransferase encoded by the bal and
and tcp [38] clusters, vanY-like genes in the bal and dbvcep clusters (Table 1), which glycosylate amino acid 4
clusters, and no obvious resistance determinant in the[13, 21]. Thus, most likely ORF9 modifies this same
cep cluster.amino acid, using an activated amino sugar instead of
Four dbv ORFs are likely to encode export functions.UDP-glucose. dbv ORF27 is likely to catalyze N-methyl-
Homologs of ORFs 24 and 35 are present in other glyco-ation of the terminal HPG residue, since it is highly re-
peptide clusters, and they encode predicted ABC- andlated to the cep methyltransferase (Table 1), which has
ion-dependent transmembrane transporters, respec-been shown to methylate in vitro advanced glycopeptide
tively (Table 1). dbv ORFs 18 and 19 (Table 1) appear tointermediates [14].
encode an additional ABC-type transporter, with ORF18The other three tailoring steps are unique to A40926
being the transmembrane partner. The best matchingbiosynthesis. Glycopeptides of the teicoplanin family
sequences to these two ORFs are also adjacent in theare N-acylated at the glucosamine moiety with an acyl
S. coelicolor genome.chain derived from fatty acid degradation [36]. dbv
Among the four putative regulatory genes present inORF23 encodes a protein highly related to members of
the dbv cluster, homologs of the putative positive regu-the acyltransferase 3 family, so it might participate in
lator dbv ORF4 are present in all glycopeptide clustersN-acylation. Comparison of the dbv genes with those
(Table 1). An additional putative positive regulator isdirecting the synthesis of teicoplanin [37] might help
encoded by dbv ORF3 (Table 1). The two members ofidentify candidate genes for this reaction.
a putative two-component signal transduction systemHomologs of dbv ORF20 are present in S. coelicolor
may also be specified by the dbv cluster, although the(Table 1) in the ramoplanin [28] and teicoplanin (M.S.
corresponding genes, ORF6 and ORF22, are not physi-and S.D., unpublished results) gene clusters. Ramo-
cally linked (Table 1).planin and teicoplanin also contain a mannosyl residue
Three additional genes are present in the dbv cluster.attached to an HPG residue of the peptide core. Interest-
ORF30, located just 5 to the dpgAD homologs, encodesingly, all three polypeptides contain motifs typical of the
a polypeptide highly similar to hypothetical proteins ofprotein mannosyltransferases family (Figure 4). These
unknown function identified from bacterial genome se-data suggest a role for ORF20 in A40926 mannosylation.
quences (Table 1), which all display the conserved mo-
It is interesting to note that the protein mannosyltrans-
tifs typical of 4-hydroxybenzoyl-CoA thioesterases [40].
ferase family (pfam02366 from the CDD database) does
Thus, the product of ORF30 may be a thioesterase, pos-
not show any obvious resemblance to glycosyltransfer-
sibly involved in facilitating the release of a DPG precur-
ases that use NDP-activated sugars. This might be re- sor during synthesis of this polyketide-derived amino
lated to the use of other sugar-activating moieties. In acid. No significant matches to proteins of known func-
addition, while NDP-dependent glycosyltransferases tion could be found for ORFs 8 and 21. Homologs of
are located in the cytoplasm, mannosylation might take the latter are also present in the bal and cep clusters,
place on the outer side of the cytoplasmic membrane, while ORF8 is so far unique to the dbv cluster.
as suggested by the ease with which some glycopeptide
producers can mannosylate exogenously added de-
mannosylated glycopeptides [38]. Since glycopeptides Manipulation of the A40926 pathway
do not cross the cytoplasmic membrane, mannosylation In order to confirm the involvement of the dbv cluster
is likely to occur outside of the cell. in A40926 biosynthesis, we employed a gene transfer
dbv ORF29 contains motifs typical of FAD binding and system recently developed for Nonomuraea species
shows considerable matches to other proteins de- ATCC39727 (S. Stinchi et al., submitted) to construct a
scribed as hexose oxidases (Table 1). This gene is likely gene replacement mutant. A DNA segment from the dbv
to govern oxidation of the glucosamine moiety to yield cluster, in which the 5 end of ORF 8, most of ORF10,
the corresponding acid. In addition, the presence of a and the entire ORF9 was replaced by the tsr marker (see
putative signal sequence at the N terminus suggests Figure 5A), was cloned into an int-deleted version of
that the product of ORF29 is secreted, and hence that pSET152. The resulting plasmid pVHom1 was intro-
duced into the Nonomuraea chromosome by homolo-oxidation occurs outside the cytoplasm.
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Figure 4. Alignment of Putative Mannosyltransferases
The sequences are abbreviated as follows: dbv, dbv ORF20; ram, ORF19 from the ramoplanin gene cluster [28]; Sc, S. coelicolor CAC32663.1
[45]. Residues indicated in red in the consensus line are present in the protein mannosyltransferase family (http://www.ncbi.nlm.nih.gov/
Structure/cdd).
gous recombination (see Experimental Procedures). In from replacement of the wild-type segment with the in
vitro mutated copy (Figure 5A). (The tsr marker turnedthis way, a first strain was isolated, designated Non1,
and carrying the construct of Figure 5A, integrated by out to be unsuitable for recognizing gene replacement
events due to high background growth of the wild-type.)a single crossover event. Serial passages of Non1 even-
tually yielded strain Non18-10, which showed, upon This interpretation was confirmed by Southern hybrid-
ization, which showed that the 4.0 and 2.7 kb bands inPCR analysis, the 2.7 and 1.2 kb products expected
Figure 5. Gene Replacement in Nonomuraea
(A) Scheme of gene replacement. The upper
part shows the relevant portion of the dbv
cluster, while the lower portion is a schematic
of plasmid pVHom1. The thick line denotes
the DNA fragment cloned in pWHom1, while
the thin line represents the flanking segments
in the dbv cluster. The white arrows indicate
the affected ORFs, while the gray arrow rep-
resents the tsr gene. Small arrows indicate
PCR primers, and the dashed lines indicate
the segments deleted in strain Non18-10.
Relevant restriction sites are abbreviated as
follows: B, BamHI; E, EcoRI; H, HindIII; N,
NcoI; S, SacI.
(B) Southern hybridization. Genomic DNA
from Nonomuraea wild-type (lane 2), strain
Non1 (lane 3), strain Non18-10 (lane 4), and
control pVHom1 (lane 1) were digested with
NcoI and hybridized to the 6.3 kb BamHI frag-
ment (A). Fragment sizes (in kb) are indicated.
(C) Bioassay on B. subtilis BAU102: i, strain
Non18-10; ii, wild-type.
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the wild-type DNA were replaced by bands of 3.5 and clinical development. The dbv cluster, required for
A40926 formation, represents the first example of a2.2 kb (Figure 5B), consistent with the predictions from
Figure 5A. On the basis of the extent of the deletion gene cluster from a Nonomuraea species and the first
description of the genes required for formation of aintroduced, strain Non18-10 is expected to be devoid
of functional products of ORF8 through ORF10. Strain teicoplanin-like glycopeptide. The cluster consists of
37 ORFs and presents some unique features absentNon18-10 produced a significantly lower amount of
antimicrobial activity than the parent strain (Figure 5C). from other glycopeptide clusters, including diver-
gently transcribed genes encoding the A40926 NRPS.The metabolites produced by strain Non18-10 were
analyzed by LC-MS and compared with those of the Some dbv genes could be assigned to particular tai-
loring steps: ORF9 is responsible for glucosamine at-wild-type and with an A40926 standard. The wild-type
produced a major peak with a 13.9 min retention time tachment, while ORFs 20 and 29 are likely to encode
a mannosyltransferase and a hexose oxidase. These(Figure 6A), which showed a molecular ion [MH] of 1731
in the corresponding mass spectrum, as did the A40926 and other dbv genes that specify tailoring steps unique
to A40926 formation can represent additional toolsstandard. In the case of strain Non18-10, the 13.9 min
peak was absent, and a major peak was observed with for eventually generating glycopeptide analogs. A new
glycopeptide derivative was obtained after deletion ofa 6.7 min retention time and molecular weight of 1306
(Figure 6B). Furthermore, this peak shows a UV spec- three dbv genes. The ability to genetically manipulate
the A40926 producer should help elucidate the role oftrum (not shown) indistinguishable from that of A40926,
with a maximum at 278 nm. (The HPLC profile of Figure dbv genes and should allow the production of new
glycopeptides of the teicoplanin family that are cur-6B shows also another major peak at 13.1 min, with a
molecular weight of 833 and a UV spectrum unrelated rently hard to make by synthetic or semisynthetic ap-
proaches.to that of A40926.) The 1306 molecular weight is compat-
ible with the A40926 mannosyl aglycone devoid of chlo-
rine atoms. The isotopic profile of the 6.7 min peak Experimental Procedures
demonstrates the absence of chlorine atoms, and MS-
Isolation of the dbv ClusterMS fragmentation yielded a first fragment at 1144 mass
A cosmid library of Nonomuraea ATCC39727 DNA in the vectorunits, consistent with loss of the mannose unit from the
Supercos was prepared by the Stratagene customer library service
molecular ion. These results strongly indicate that the (Stratagene, La Jolla, CA). An enriched library of Nonomuraea DNA
main metabolite produced by strain Non18-10 is made with 2–3 kb BamHI fragments in pUC19 was screened by
the mannosyl-deschloroaglycone of A40926 and con- hybridization to the bal dpgA gene [15]. The insert from one positive
clone was then used to screen the cosmid library, together with thefirm the hypothesized role for the product of ORFs 9
oligo probes Pep6 and Pep8 [41] and the bal gtfB gene [4]. Afterand 10 as a glycosyltransferase and a halogenase, re-
restriction mapping and chromosome walking, seven cosmids werespectively. Since the deletion strain Non18-10 carries
identified, leading to the set of overlapping inserts shown in Figure
also a defect in ORF8, this latter gene could either play 2. Cosmids 1B1, 11A5, and a 20 kb ClaI deletion of cosmid 7C7
no essential role in A40926 formation or be required for were sequenced by custom sequencing (SeqLab, Gottingen, Ger-
modification of the glucosamine moiety. The construc- many). The dbv sequence was analyzed with programs from the
Wisconsin Package (version 10, Accelrys). Prediction of amino acidtion of mutant strains lacking only ORF8 should distin-
specificity of the A domains was performed as described [30, 31]guish between these two possibilities.
using the search available at http://raynam.chm.jhu.edu/nrps/
index2.html.Significance
Gene ReplacementThe glycopeptide A40926 is the precursor of the semi-
A 6.3 kb BamHI fragment spanning from ORF5 to ORF11 was cloned
synthetic glycopeptide dalbavancin, currently under into pUC18. Two internal SacI fragments, for a total of 2.8 kb, were
then replaced with the tsr gene, PCR amplified from pIJ39 [42].
Then, the resulting 5.4 kb insert was excised as an EcoRI-HindIII
fragment and cloned into the corresponding sites of pSET152 [43],
generating plasmid pVHom1. (This cloning strategy removes 1.2 kb
from the 3 end of the int gene in pSET152.) Conjugation between
E. coli ET12567 (pUB307) harboring pVHom1 and Nonomuraea
ATCC39727 was performed as described [41]. Briefly, an overnight
culture of the donor strain and an exponential, sonicated culture of
the recipient strain were plated on BTT agar (10 g/l glucose, 1 g/l
yeast extract, 1 g/l beef extract, 2 g/l casitone, 20 g/l agar). Plates
were incubated for 24 hr at 28C before overlaying them with 3 ml
soft agar containing 280 and 200 g apramycin and nalidixic acid,
respectively. After a further 3 week incubation, one apramycin-resis-
tant Nonmuraea exconjugant was isolated and designated strain
Non1. This apramycin-resistant strain was grown under nonselective
conditions in RARE3 medium (10 g/l glucose, 4 g/l yeast extract, 10
g/l malt extract, 2 g/l Bacto peptone, 2 g/l MgCl2·H2O, 5 g/l glycerol)
for 4 days before plating on BTT agar. The resulting colonies were
screened for plasmid loss by PCR using the primer pairs ORF5F (5-
GTGGCCGGGGTGCTGGAGCGGATCG-3) and tsr1R (5-GCG
Figure 6. Metabolite Analysis ATGCCGATGGGGGTGTCGTGGC-3) or tsr1F (5-CCGAGAC
CGTGAGCCGGCGCAAGCC-3) and ORF11R (5-TGGTCGGTCAGCHPLC analysis of culture media of (A) wild-type and (B) strain
Non18-10. TGTCGGTCTATGATCCG-3), as shown in Figure 5A. For PCR analy-
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sis, a loopful of mycelium from an agar plate was resuspended in 100 7. Chen, H., Thomas, M.G., Hubbard, B.K., Losey, H.C., Walsh,
C.T., and Burkart, M.D. (2000). Deoxysugars in glycopeptidel of distilled water, incubated at 95C for 10 min, and centrifuged at
13,200 	 g for 5 min. Then, 14 l of the supernatant was used for antibiotics: enzymatic synthesis of TDP-L-epivancosamine in
chloroeremomycin biosynthesis. Proc. Natl. Acad. Sci. USA 97,PCR amplification. Southern hybridizations were performed using
the nonradioactive DIG DNA labeling and detection kit (Roche). 11942–11947.
8. Hubbard, B.K., Thomas, M.G., and Walsh, C.T. (2000). Biosyn-
thesis of L-p-hydroxyphenylglycine, a non-proteinogenic aminoMetabolite Identification
acid constituent of peptide antibiotics. Chem. Biol. 7, 931–942.Nonomuraea was grown in RARE3 medium for 7 days at 28C. After
9. Trauger, J.W., and Walsh, C.T. (2000). Heterologous expressioncentrifugation, 90 ml of broth was mixed with 1 volume of 0.1 M
in Escherichia coli of the first module of the nonribosomal pep-sodium borate (pH 12) and kept for 1 hr at 50C. After filtering through
tide synthetase for chloroeremomycin, a vancomycin.type gly-a 0.45 m filter, the filtrate was brought to pH 7.5 with HCl, and
copeptide antibiotic. Proc. Natl. Acad. Sci. USA 97, 3112–3117.antibiotic activity was evaluated by agar diffusion against Bacillus
10. Chen, H., Tseng, C.C., Hubbard, B.K., and Walsh, C.T. (2001).subtilis BAU-102 [44]. For HPLC and MS analysis, the extracts were
Glycopeptide antibiotic biosynthesis: enzymatic assembly ofadsorbed onto 7.5 ml of an HP20 resin prewashed with CH3OH and
the dedicated amino acid monomer (S)-3,5-dihydroxyphenyl-equilibrated with 20 mM ammonium formate (pH 6.6) (buffer A). After
glycine. Proc. Natl. Acad. Sci. USA 98, 14901–14906.a 12 hr incubation, the resin was recovered by filtration, washed
11. Li, T.L., Choroba, O.W., Hong, H., Williams, D.H., and Spencer,with 15 ml buffer A, and eluted with 20 ml of 1:1 1.5% NH4OH:
J.B. (2001). Biosynthesis of the vancomycin group of antibiotics:CH3COCH3. The resulting fraction was dried and dissolved at 10
characterisation of a type III polyketide synthase in the pathwaymg/ml in 70:30 CH3CN: buffer A. Metabolites (1 mg) were injected
to (S)-3,5-dihydroxyphenylglycine. Chem. Commun. 2001,onto a 5-Symmetry C18 column (4.6 mm 	 25 cm) using a Waters
2156–2157.system (Waters Chromatography, Milford, MA). Metabolites were
12. Li, T.L., Choroba, O.W., Charles, E.H., Sandercock, A.M., Wil-resolved employing a binary solvent system composed of phase A
liams, D.H., and Spencer, J.B. (2001). Characterisation of a hy-(5:95 20 mM ammonium formate [pH 4.5]: CH3CN) and phase B
droxymandelate oxidase involved in the biosynthesis of two(100% CH3CN), using a linear gradient from 30% to 70% phase B
unusual amino acids occurring in the vancomycin group of anti-in 30 min at 1.0 ml/min. A zero-dead-volume tee (Valco, Houston,
biotics. Chem. Commun. 2001, 1752–1753.TX) was used to produce a 5:95 post-column effluent split, diverting
13. Losey, H.C., Peczuh, M.W., Chen, Z., Eggert, U.S., Dong, S.D.,the majority of the effluent to a Waters 996 Photodiode Array Detec-
Pelczer, I., Kahne, D., and Walsh, C.T. (2001). Tandem actiontor and the remainder to the ESI interface of a Finnigan LCQ Duo
of glycosyltransferases in the maturation of vancomycin andmass spectrometer. Full scan mass spectra were acquired in posi-
teicoplanin aglycones: novel glycopeptides. Biochemistry 40,tive (profile or centroid) mode from 600 to 1900 amu, with a data-
4745–4755.dependent zoomscan and MS2 programmed in the selected mass
14. O’Brien, D.P., Kirkpatrick, P.N., O’Brien, S.W., Staroske, T.,range. MS2 spectra were obtained with an isolation width of 3 amu
Richardson, T.I., Evans, D.A., Hopkinson, A., Spencer, J.B., andand normalized collision energy of 28%.
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